Zobrazeno 1 - 10
of 122
pro vyhledávání: '"R E, Kimura"'
Autor:
Michael R. Uhing, R E Kimura
Publikováno v:
Journal of Clinical Investigation. 95:2799-2805
A method is described for determining the fraction of intestinal 3-O-methyl-glucose (3OMG) absorption that occurs by active transport in chronically catheterized rats without the influence of anesthesia or surgical bowel manipulation. That fraction w
Autor:
R E Kimura, Michael R. Uhing
Publikováno v:
Journal of Clinical Investigation. 95:2790-2798
The effects of surgical bowel manipulation and anesthesia on intestinal glucose absorption were determined in chronically catheterized rats. Total and passive rates of glucose absorption were measured using 3-O-methyl-glucose (3OMG) and L-glucose, me
Publikováno v:
Digestive diseases and sciences. 43(10)
The use of high-dose pancreatic enzymes by patients with cystic fibrosis was associated with the development of fibrosing colonopathy. Preliminary studies indicated that the infusion of high-dose pancreatic enzymes alone did not cause intestinal dama
Autor:
R E, Kimura
Publikováno v:
Clinics in perinatology. 23(2)
In the presence of glutamine, glucose, and 3-hydroxybutyrate, glutamine is the preferred oxidative substrate in enterocytes of suckling and weaned rats. Our studies of changes in intestinal metabolism in the developing rat clearly indicate that the o
Publikováno v:
The Nursing clinics of North America. 30(1)
Identifying a premature infant's response to noxious stimuli and knowing when it is appropriate to intervene are major issues for the caregiver. After completing a pilot study, the staff of a 42-bed neonatal intensive care unit targeted improved pain
Autor:
Stephen D. Hall, Y. C. Chen, Raymond E. Galinsky, V.A. Jiyamapa‐Sherna, R. E. Kimura, M. A. Hamman
Publikováno v:
Clinical Pharmacology & Therapeutics. 75:P81
Drug-drug interactions are a leading cause of death in the U.S. CYP3A metabolism is the predominant pathway for drug metabolism. Itraconazole (ITZ) alters CYP3A activity resulting in clinically significant drug interactions. To date, in vitro studies
Autor:
Stephen D. Hall, Y. C. Chen, M. A. Hamman, V.A. Jiyamapa‐Sherna, R. E. Kimura, Raymond E. Galinsky
Publikováno v:
Clinical Pharmacology & Therapeutics. 73:P16-P16
Publikováno v:
Frontiers in Drug Discovery; 2024, p1-13, 13p
Publikováno v:
Development (09501991); Oct2024, Vol. 151 Issue 20, p1-5, 5p
Autor:
Stuart, Tim
Publikováno v:
Biochemical Society Transactions; Aug2024, Vol. 52 Issue 4, p1827-1839, 13p